Literature DB >> 4448415

Use of bumetanide in the treatment of ascites due to liver disease.

P J Moult, M R Lunzer, D B Trash, S Sherlock.   

Abstract

Bumetanide is an effective diuretic for the treatment of ascites. Fifteen out of 17 patients with chronic liver disease responded satisfactorily and the incidence of hepatic encephalopathy and electrolyte disturbances was similar to that previously observed with frusemide. Colicky abdominal pain was reported in three patients but no other adverse effects were noted. An unexpected response was obtained in two patients who had diuresis without natriuresis.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4448415      PMCID: PMC1413073          DOI: 10.1136/gut.15.12.988

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  5 in total

1.  BODY AND SERUM POTASSIUM IN LIVER DISEASE. I. RELATIONSHIP TO HEPATIC FUNCTION AND ASSOCIATED FACTORS.

Authors:  T H CASEY; W H SUMMERSKILL; A L ORVIS
Journal:  Gastroenterology       Date:  1965-02       Impact factor: 22.682

Review 2.  Clinical disorders of urine concentration and dilution.

Authors:  J T Harrington; J J Cohen
Journal:  Arch Intern Med       Date:  1973-06

3.  Bumetanide, a new potent diuretic. A clinical evaluation in congestive heart failure.

Authors:  K H Olesen; B Sigurd; E Steiness; A Leth
Journal:  Acta Med Scand       Date:  1973 Jan-Feb

4.  Complications of diuretic therapy in hepatic cirrhosis.

Authors:  S Sherlock; B Senewiratne; A Scott; J G Walker
Journal:  Lancet       Date:  1966-05-14       Impact factor: 79.321

5.  Bumetanide: potent new "loop" diuretic.

Authors:  M J Asbury; P B Gatenby; S O'Sullivan; E Bourke
Journal:  Br Med J       Date:  1972-01-22
  5 in total
  4 in total

1.  Diuretic action of bumetanide in advanced chronic renal insufficiency.

Authors:  K J Berg; A Tromsdal; T E Wideroe
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

Review 2.  Pharmacotherapy of ascites associated with cirrhosis.

Authors:  P Ginès; V Arrovo; J Rodés
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

3.  Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.

Authors:  V Arroyo; J Bosch; R Casamitjana; J Cabrera; F Rivera; J Rodés
Journal:  Gut       Date:  1980-10       Impact factor: 23.059

Review 4.  Off-Label Use of Bumetanide for Brain Disorders: An Overview.

Authors:  Shivani C Kharod; Seok Kyu Kang; Shilpa D Kadam
Journal:  Front Neurosci       Date:  2019-04-24       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.